Výsledky vyhledávání - "blood clotting factor 8 antibody"

Intensive peri-operative use of factor VIII and the Arg593 → Cys mutation are risk factors for inhibitor development in mild/moderate hemophilia A

Autor: Marjolein Peters, Corien L. Eckhardt, Pieter Willem Kamphuisen, L.A. Menke, J.H. Van Der Lee, Karin Fijnvandraat, Ronald B. Geskus, C. H. van Ommen

Publikováno v: Journal of thrombosis and haemostasis, 7(6), 930-937. Wiley-Blackwell
Journal of Thrombosis and Haemostasis, 7(6), 930-937. Wiley

Background: A severe and challenging complication in the treatment of hemophilia A is the development of inhibiting antibodies (inhibitors) directed towards factor VIII (FVIII). Inhibitors aggravate bleeding complications, disabilities and costs. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c5c7d51c770b9be08db893684821611
https://doi.org/10.1111/j.1538-7836.2009.03357.x

Zobrazit plný text záznamu

Low-dose immune tolerance induction for paediatric haemophilia patients with factor VIII inhibitors

Autor: Türkiz Gürsel, Hale Ören, Tülin Tiraje Celkan, T. Sayli, Elif Güler Kazanci, Kaan Kavakli, Birol Baytan, Ayşegül Ünüvar

Publikováno v: Haemophilia. 14:315-322

The development of an inhibitor against factor VIII (FVIII) is a serious complication in children with haemophilia A. Immune tolerance induction (ITI) therapy is generally considered to be the best approach to eradicate the inhibitor. In this paper,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a8703146e320f5033f06d80e373a537
https://doi.org/10.1111/j.1365-2516.2007.01621.x

Zobrazit plný text záznamu

Successful treatment of acquired haemophilia with prednisolone therapy

Autor: Uludağ Üniversitesi/Tıp Fakültesi/İç Hastalıkları Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Deri ve Zührevi Hastalıklar Anabilim Dalı., Ali, Rıdvan, Özçelik, Tülay, Özkalemkaş, Fahir, Özkocaman, Vildan, Ozan, Ülkü, Yalçın, M., Sarıcaoğlu, Hayriye, Tunalı, Ahmet, AAH-1854-2021, AAG-8495-2021

Acquired hemophilia is a rare, life threatening coagulopathy in adults caused by the development of autoantibodies against to factor VIII. No general consensus exists on the best therapeutic approach. We report here a case that presented with extensi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______9458::ef5b1a1275250c2b53fed7b8911f4c75
http://hdl.handle.net/11452/31644

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání